These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13466788)

  • 21. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE; Gonzalez-Pares EN; Rivera C
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical reasoning and decision-making in practice. A man with inexplicable joint pain and subsequent poor clinical condition].
    Kroon T; Houtman PM; Jansen TL; Veeken H; Hart W
    Ned Tijdschr Geneeskd; 2006 Sep; 150(38):2078-84. PubMed ID: 17036857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The relation between primary chronic polyarthritis and visceral lupus erythematosus on the basis of serological reactions].
    GSELL O; MIESCHER P
    Helv Med Acta; 1958 Oct; 25(4):437-43. PubMed ID: 13610224
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibodies against thyroid autoantigens in patients with chronic evolutive polyarthritis and in patients with chronic systemic lupus erythematosus].
    CARROZZINI B; RIPA R
    Arcisp S Anna Ferrara; 1962; 15():1247-74. PubMed ID: 14018916
    [No Abstract]   [Full Text] [Related]  

  • 27. A rare case of systemic autoimmune disease with intricate features of systemic sclerosis, lupus, polymyositis and rheumatoid arthritis. Overlap syndrome or mixed connective tissue disease?
    Radulescu D; Pripon S; Ciovicescu F; Constantea NA
    Acta Reumatol Port; 2007; 32(3):292-7. PubMed ID: 17932479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Raynaud's syndrome and scleroderma. II. Development of generalized scleroderma in a case of Raynaud's disease].
    JABLONSKA S; LUKASIAK B; BUBNOW B
    Pol Tyg Lek (Wars); 1957 Oct; 12(40):1528-30. PubMed ID: 13505261
    [No Abstract]   [Full Text] [Related]  

  • 30. Rembrandt's Maria Bockenolle has a butterfly rash and digital deformities: overlapping syndrome of rheumatoid arthritis and systemic lupus erythematosus.
    Hayakawa S; Komine-Aizawa S; Osaka S; Iida T; Hayakawa J; Nishinarita S; Nemoto N
    Med Hypotheses; 2007; 68(4):906-9. PubMed ID: 17113236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis].
    Dijkmans BA; van Schaardenburg D; van der Horst-Bruinsma IE; Reesink HW; Vandenbroucke JP; Boers M
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):688-93. PubMed ID: 15819133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The L.E. phenomenon in rheumatoid arthritis.
    PARR LJ; SHIPTON EA; BENJAMIN P; WHITE PH
    Med J Aust; 1957 Jun; 44(26):900-5. PubMed ID: 13450735
    [No Abstract]   [Full Text] [Related]  

  • 34. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
    Vogt B; Führnrohr B; Müller R; Sheriff A
    Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive hyperemia in Raynaud's disease.
    Pratesi F; Corsi C; Deidda C; Nuti A
    Biochem Exp Biol; 1977; 13(3):337-9. PubMed ID: 16296018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Random number generation evaluation in patients with systemic lupus erythematosus indicates a heterogeneous nature of central nervous system vulnerability.
    Matsukawa Y; Nagashima M; Kamei S; Tanabe E; Takahashi S; Kojima T; Taira M; Morita K; Matsuura M; Sawada S
    Scand J Rheumatol; 2006; 35(4):295-9. PubMed ID: 16882594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.